Your browser doesn't support javascript.
loading
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.
Jonker, D J; Karapetis, C S; Harbison, C; O'Callaghan, C J; Tu, D; Simes, R J; Malone, D P; Langer, C; Tebbutt, N; Price, T J; Shapiro, J; Siu, L L; Wong, R P W; Bjarnason, G; Moore, M J; Zalcberg, J R; Khambata-Ford, S.
Afiliação
  • Jonker DJ; The Ottawa Hospital Research Institute, University of Ottawa, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.
  • Karapetis CS; Flinders Medical Centre and Flinders University, Flinders Drive, Bedford Park, Adelaide, SA 5042, Australia.
  • Harbison C; Research and Development, Bristol-Myers Squibb, 100 Nassau Park Boulevard, Princeton, NJ 08540, USA.
  • O'Callaghan CJ; NCIC - Clinical Trials Group, Queens University, Cancer Research Institute, 10 Stuart Street, Kingston, ON K7P 3E3, Canada.
  • Tu D; NCIC - Clinical Trials Group, Queens University, Cancer Research Institute, 10 Stuart Street, Kingston, ON K7P 3E3, Canada.
  • Simes RJ; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, ABN 15 211 513 464, Camperdown, NSW 1450, Australia.
  • Malone DP; Research and Development, Bristol-Myers Squibb, 100 Nassau Park Boulevard, Princeton, NJ 08540, USA.
  • Langer C; Genetech Inc., 1 Dna Way, South San Francisco, CA 94080, USA.
  • Tebbutt N; Austin Health and University of Melbourne, 145 Studley Road, Heidelberg, VIC 3084, Australia.
  • Price TJ; The Queen Elizabeth Hospital and University of Adelaide, 28 Woodville Road, Woodville South SA 5011, Australia.
  • Shapiro J; Cabrini Hospital and Monash University, Isabella Street, Malvern, VIC 3144, Australia.
  • Siu LL; Princess Margaret Hospital and University of Toronto, 610 University Avenue, Suite 5-718, Toronto, ON M5G 2M9, Canada.
  • Wong RP; Cancercare Manitoba, St Boniface General Hospital, 409 Tache Avenue, Rm L1-102, Winnipeg, MB R2H 2A6, Canada.
  • Bjarnason G; Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.
  • Moore MJ; Princess Margaret Hospital and University of Toronto, 610 University Avenue, Suite 5-718, Toronto, ON M5G 2M9, Canada.
  • Zalcberg JR; Peter MacCallum Cancer Centre, Australasian Gastrointestinal Trials Group, University of Melbourne, 1 Street Andrews Place, East Melbourne, VIC 3002, Australia.
  • Khambata-Ford S; Research and Development, Bristol-Myers Squibb, 100 Nassau Park Boulevard, Princeton, NJ 08540, USA.
Br J Cancer ; 110(3): 648-55, 2014 Feb 04.
Article em En | MEDLINE | ID: mdl-24335920
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas ras / Fator de Crescimento Epidérmico / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas ras / Fator de Crescimento Epidérmico / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article